Sponsored By


Infant antibiotic use
may up asthma risk

Children’s snoring
may be tied to
allergic disease

 
  
June 20, 2007
  
Welcome to ACAAI eNews — a bi-weekly aggregated news service from the American College of Allergy, Asthma & Immunology. To be removed from this distribution list, please see instructions at bottom.
 
Top Stories
 
Distance Learning
   
Drugs and Devices
   
Association News
   
Fellows-in-Training
   
Periodicals
Calendar
   
Archive
FIT Archive
Members:
update 
e-mail address
here
   
Non-members:
subscribe here

 

ACAAI Home
 
Distance Learning
ACAAI Podcast/Vodcast Library
Link

2006 ACAAI Annual Meeting CD-ROM
Plenary Sessions
Literature Review
International Food Allergy Symposium
Link
 
Periodicals
Annals of Allergy, Asthma and Immunology
Current issue

• AllergyWatch
Current issue
 
Calendar

JUNE
The Pennsylvania Allergy and Asthma Association Annual Scientific Meeting
June 22-24, Hershey, Pa.
Tel: 888-633-5784
Link

JULY
Intermountain West Allergy Association
Pending ACAAI Joint Sponsorship
July 19-23, Spokane, Wash.
Tel: 509-924-9722
E-mail 

2007 International Congress on Respiratory Viruses
The Macrae Group
July 20-22, Colorado Springs, Colo.
Tel: 212-988-7732
E-mail 
Link


25th Annual Aspen Allergy Conference
Pending ACAAI Joint Sponsorship
July 24-28, Aspen, Colo.
Conference Coordinator: Jill Hibbeln
Tel: 720-384-5917
E-mail
Link

AUGUST
Tennessee Society of Allergy, Asthma & Immunology
Pending ACAAI Joint Sponsorship
Aug. 18-20, Knoxville, Tenn.
Tel: 865-342-7057
E-mail


SEPTEMBER
The Long Island Allergy & Asthma Society
Pending ACAAI Joint Sponsorship
Sept. 9, Manhasset
Tel: 516-365-6077
E-mail

New York Allergy and Asthma Society
Pending ACAAI Joint Sponsorship
Sept. 19, New York, N.Y.
Tel: 212-288-2278
E-mail

OCTOBER
Meadowbrook Med Ed Research Foundation at NUMC
Pending ACAAI Joint Sponsorship
Oct. 4, East Meadow, N.Y.
Tel: 718-631-9440
E-mail

1st International Congress on Exacerbations of Airway Disease (ICEAD)
The Macrae Group
Oct. 4-7, San Juan, Puerto Rico
Tel: (+1) 212.988.7732
E-mail
Link

II Immunotherapy Course: The Insights of Effective Vaccine for Allergy
Mexican College of Pediatric
Allergy & Immunology
Recognized by ACAAI
Oct. 12-13, Mexico City
Tel: +52-55-9000-2008
E-mail
Link

Oregon Society of Allergy, Asthma & Immunology
Pending ACAAI Joint Sponsorship
Oct. 13-14, Mt. Vernon, Va.
Tel: 360-708-9555
E-mail

New York Allergy & Asthma Society
Pending ACAAI Joint Sponsorship
Oct. 26, Brooklyn, N.Y.
Tel: 718-377-0011
E-mail


ONGOING
World Allergy Organization Society Meetings

ACAAI CME Website
Contact: Mary Campbell
Tel: 847-427-1200
E-mail

 Sponsored By

 
  
Top Stories
 

Study: Asthma not controlled in 55 percent
with moderate-to-severe disease
A recent study in the Journal of Allergy and Clinical Immunology found that asthma was not controlled in 55 percent of Americans with moderate-to-severe asthma, despite most having health insurance and regularly visiting a general practitioner. Researchers at Wake Forest University School of Medicine's Center for Human Genomics examined data from a Web-based survey of 1,812 patients with an asthma diagnosis for at least one year and receiving multiple controller medications. Only 26 percent of subjects with controlled asthma and 35 percent with uncontrolled asthma had received an asthma action plan. 

Infant antibiotic use may increase asthma risk
Antibiotic use during the first year of life may increase a child’s risk of developing asthma, according to a longitudinal Canadian study in Chest. Researchers at the University of Manitoba in Winnipeg looked at health care and prescription databases in Manitoba, assessing the association between antibiotic prescription use during the first year of life and asthma at 7 years in a 1995 birth cohort of 13,116 children. The risk was highest among infants who had received more than four courses of antibiotics for non-respiratory tract infections, as well as those who received prescriptions for broad-spectrum antibiotics — especially broad-spectrum cephalosporins. 

Children’s snoring may be tied to allergic disease
Risk factors for snoring are similar to risk factors for allergic disease, and snoring may even be part of the allergic spectrum of diseases, according to an Australian study in Pediatric Pulmonology. Scientists at the Woolcock Institute for Medical Research in Sydney evaluated a subgroup of 213 5-year-olds participating in the Childhood Asthma Prevention Study whose parents reported that they had rhinitis for at least one week during the previous year. Of those children, nearly 60 percent snored at least once a week and 26 percent snored more than three nights a week. First-born children were 2.5 times more likely to snore than children with older siblings, and a mother who smoked at home during a their first year increased snoring risk 2.4-fold. Children with asthma were 2.51 times more likely to snore, and children with eczema were 2.29 times more likely to be snorers. Body mass index had no relationship to snoring.

 

A message from ACAAI President Dr. Daniel Ein

The College has sometimes faced criticism from members because it is involved with, and devotes considerable resources to, various international activities and organizations. The leadership is aware that attendance by officers and Board members at meetings overseas is viewed by some as a boondoggle and an unwarranted privilege. I would agree that it is a privilege but would also argue that it is an important activity that is important for the College — and allergy in general.

In my inaugural remarks last November, I said, “We will continue to participate in international meetings to teach, but also to learn.” Some in the audience might have been skeptical that we have much to learn from colleagues overseas. My experience is that I learn a great deal every time I interact with allergists in their home countries. For example, we know that our European colleagues have considerable experience with sublingual immunotherapy (SLIT). We also know that this treatment is attracting wide attention in the United States. I think it is crucial for us to learn as much as possible about SLIT in order to help us evaluate it and to respond to numerous questions from our patients. Speaking with those who have prescribed it is one of many sources of information.

I was recently at a meeting of the Hungarian Allergy and Clinical Immunology Society, where I was graciously received by its president, Prof. Kristof Nekam, and by numerous members. There were fruitful discussions about how allergy is practiced in our two countries and conversations about the socioeconomic problems of medical practice in our two countries. (We complain about the lack of compensation for what we do but in Hungary, pay is so poor that many Hungarian physicians, who are extremely well-trained, are leaving to work elsewhere.) We also discussed possibilities for collaboration and joint meetings. And Dr. Larry DuBuske gave, as an introduction to his talk, an impassioned presentation about the advantages of College membership.

Some 500 international allergists, many of them in developing countries, have joined as international affiliate members to have access to the “virtual” resources of the College, including Annals and AllergyWatch online, Web site information and ACAAI eNews.

These kinds of interactions are repeated frequently throughout the year, all over the world, and are one of the cornerstones of our mission. I consider our international involvements an illustration of the old adage that one has to give in order to receive. And, believe me, we do receive a great deal from them.

Our international commitments also extend to the World Allergy Organization but this involves a different set of issues, which I intend to discuss in a future message.

 
*********************************************
Due to technical difficulties, we are repeating the poll on Maintenance of Certification discussed in the message from Dr. Mark L. Corbett, Director, ABAI Board of Directors featured in the May 23 issue of ACAAI eNews. Please take a minute to answer the poll or comment:

Poll
If you currently hold a lifetime certificate, do you plan to participate in MOC?

Poll


 
Drugs and Devices
 

FDA approves once-daily antihistamine Xyzal
The U.S. Food and Drug Administration recently approved levocetirizine dihydrochloride (brand name Xyzal) to treat nasal allergies and chronic hives in people 6 years and older, according to manufacturers UCB and sanofi-aventis. A statement by the companies said the drug significantly reduced symptoms of sneezing, itchy and runny nose, and itchy eyes during clinical testing involving more than 2,000 people. It also reduced the severity of itching and the number and size of wheals among people with chronic hives. Common side effects included fatigue, dry mouth, and nasal inflammation.  

 
Association News
 

Literature Review Course in Philly vodcast weekly
View presentations from the popular Literature Review Course, Everything You Should Have Read Last Year, But Didn’t, held at the ACAAI Annual Scientific Meeting last November, as video podcasts (vodcasts) – when you want, where you want.

Users can retrieve files manually from the College Web site or subscribe at no cost to an RSS feed which will automatically send an alert when a new presentation is posted. Members can view 30-minute vodcasts of key sessions on their computers or download them as files directly to portable media players.

Each vodcast contains the original audio and presentation slides and can be viewed from a computer or downloaded to a portable media player (such as an iPod).

The new Literature Review Course vodcasts include:
Basic Immunology and Genetics for the Allergist – Dr. David A. Khan (June 20–26)
Update in Clinical Immunology – Dr. John M. Routes (June 27–July 3)
Occupational and Environmental Allergy – Dr. Mark S. Dykewicz (July 4–10)

Previous vodcasts from the International Food Allergy Symposium and the “Asthma Control: How Are We Doing?” symposium are archived for continued viewing.

The ACAAI vodcast program is sponsored by an unrestricted educational grant from GlaxoSmithKline.

Drs. Alan and David Redding to star on new
TLC Network TV show, ‘Diagnosis X’

Identical twin fellows-in-training Dr. Alan R. Redding, University of Tennessee Health Science Center in Memphis, and Dr. David R. Redding, University of Texas Medical Branch in Galveston, Texas, will be acting out an actual allergy-immunology case together on one episode of a new TLC Network television drama series titled Diagnosis X starting July 25.

Producers recruited the twins at a fellows-in-training event at the 2007 AAAAI scientific meeting in San Diego. “They went to the party hoping to find young doctors who would be willing and able to provide them with a story and play themselves. The producers walked up to us and asked if we wanted to be on television,” said Dr. Alan Redding.

Participating doctors in Diagnosis X provide an interesting case, and the production company writes a script based on the case. Dr. Alan Redding said the show is unique and spontaneous, and although they received tips during filming, they both actually play themselves.

In their episode, Dr. Alan Redding treats a patient with IPEX Syndrome, based on a case that he is submitting as an abstract at the ACAAI Annual Meeting. IPEX Syndrome is a rare, inherited condition characterized by immune dysfunction, polyendocrinopathy, enteropathy and X-linked recessive inheritance. IPEX syndrome leads to death without prompt diagnosis. He, however, has had good outcomes treating the disease.

Dr. David Redding was written into the script as his twin and another doctor on the case. “Alan’s case is well-suited for the show. Even though I was acting a part, we were residents together and often consulted with each other regarding our patients. I am glad they were able to include me in the program. It was a lot of fun,” he said.

Donated items needed for Silent Auction
The Alliance, the College and the Foundation will again host a silent auction at the ACAAI Annual Meeting in Dallas. The proceeds will help support clinical research and education through Young Faculty Awards, Scholars Return Awards and the projects of the Consortium on Children’s Asthma Camps.

We need your support for this worthwhile cause by donating and soliciting quality items including artwork, trips, services, gift items, jewelry, tickets to major events or hand-crafted items. Cash donations are also welcome for purchasing auctioned items – an excellent way to add value to your contribution. The auction items will be available for viewing in the Alliance Hospitality Suite Friday, and Saturday morning. The auction will be held Saturday night, Nov. 10, at the Welcome Reception.

For more details or to make a donation, please call Marcee Claflin at (405) 340-1274 or e-mail marceeh519@aol.com.

 
Fellows-in-Training
 

Board Review Corner
Welcome to the Board Review Corner prepared by Soo Kim-Delio, M.D., Senior Representative of ACAAI’s fellows-in-training (FITs) to the Board of Regents. The Board Review Corner is your chance to test your Board preparedness.

To refer to a previous Board Review Corner, click the “FIT Archive” link in the left column.

Review Questions: Chapter 3 of Pediatric Allergy: Principles & Practices, edited by Donald Y.M. Leung, et al. Review questions were written by Drs. Bret Haymore, Jiun Yoon and Soo Kim-Delio, Walter Reed Army Medical Center. 


Copyright © 2007 American College of Allergy, Asthma & Immunology. All rights reserved.

E-newsletter services provided by the medical editors at Ascend Media, LLC.

Do you have news, responses or opinions to share with us? Please e-mail the association office at enews@acaai.org
  
THIS E-MAIL WAS SENT FROM A “SEND-ONLY” MAILBOX. Please DO NOT REPLY to this e-mail.
ACAAI eNews is sent as a membership benefit of the American College of Allergy, Asthma & Immunology. If you would prefer not to receive future issues and want to remove your name from our mailing list, please -click here-